EP2435387 - METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.12.2015 Database last updated on 24.08.2024 | Most recent event Tooltip | 04.12.2015 | Application deemed to be withdrawn | published on 06.01.2016 [2016/01] | Applicant(s) | For all designated states Duke University 2812 Erwin Road, Suite 306 Durham, NC 27705 / US | [2012/14] | Inventor(s) | 01 /
WARNER, David, S. Duke University 2812 Erwin Road Suite 306 Durham, NC 27705 / US | 02 /
BATINIC-HABERLE, Ines 1 Cotswold Place Durham, NC 27707 / US | 03 /
SHENG, Huaxin Duke University 2812 Erwin Road Suite 306 Durham, NC 27705 / US | 04 /
SPASOJEVIC, Ivan 1 Cotswold Place Durham, NC 27707 / US | [2012/14] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
Former [2012/14] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE | Application number, filing date | 10781161.4 | 26.05.2010 | WO2010US36256 | Priority number, date | US20090224606P | 10.07.2009 Original published format: US 224606 P | US20090181273P | 26.05.2009 Original published format: US 181273 P | [2012/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010138633 | Date: | 02.12.2010 | Language: | EN | [2010/48] | Type: | A1 Application with search report | No.: | EP2435387 | Date: | 04.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.12.2010 takes the place of the publication of the European patent application. | [2012/14] | Search report(s) | International search report - published on: | US | 02.12.2010 | (Supplementary) European search report - dispatched on: | EP | 15.02.2013 | Classification | IPC: | C07B47/00, C07D487/22, A61K31/409, A61K31/4425 | [2013/12] | CPC: |
C07D487/22 (EP,US);
A61K31/409 (EP,US);
A61K31/4425 (EP,US);
A61P25/00 (EP);
A61P7/04 (EP);
A61P9/10 (EP)
|
Former IPC [2012/14] | C07B47/00, C07D487/22 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/14] | Title | German: | VERFAHREN ZUR BEREITSTELLUNG EINES NERVENSCHUTZES DURCH DIE VERWENDUNG VON PORPHYRINEN | [2012/14] | English: | METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS | [2012/14] | French: | MÉTHODE CONSISTANT À FOURNIR UNE NEUROPROTECTION AU MOYEN DE PORPHYRINES SUBSTITUÉES | [2012/14] | Entry into regional phase | 22.12.2011 | National basic fee paid | 22.12.2011 | Search fee paid | 22.12.2011 | Designation fee(s) paid | 22.12.2011 | Examination fee paid | Examination procedure | 22.12.2011 | Examination requested [2012/14] | 16.09.2013 | Amendment by applicant (claims and/or description) | 20.01.2014 | Despatch of a communication from the examining division (Time limit: M06) | 31.10.2014 | Reply to a communication from the examining division | 17.03.2015 | Despatch of a communication from the examining division (Time limit: M04) | 28.07.2015 | Application deemed to be withdrawn, date of legal effect [2016/01] | 26.08.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/01] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.01.2014 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 31.10.2014 | Request for further processing filed | 31.10.2014 | Full payment received (date of receipt of payment) Request granted | 19.11.2014 | Decision despatched | Fees paid | Renewal fee | 25.05.2012 | Renewal fee patent year 03 | 28.05.2013 | Renewal fee patent year 04 | 27.05.2014 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.05.2015 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0075144 (UNIV PRINCETON [US], et al) [Y] 1-3,7-13 * See the porphyrin compounds defined in the claims and examples and in particular those having RN: 312700-30-4, 312700-31-5, 312700-37-1, 312700-34-8, 312700-35-9 and their use in the treatment of stroke, ischemia reperfusion injury, ischemic heart disease, spinal cord trauma, ischemia as result of myocardial infarction and stroke, which are mentioned in page 2, lines 12-16; page 21 lines 20-22 and page 23, lines 15-31. *; | [Y]WO2008045358 (TRUSTEES OF PRINCETON [US], et al) [Y] 1-3,7-13 * See the porphyrin compounds having RN: 1018810-20-2 and 1018810-21-3, and their use for the treatment of stroke, ischemia - reperfusion injury, ischemic heart failure (claim 41) *; | [Y]WO03103680 (UNIV DUKE [US], et al) [Y] 1-3,7-13 * See the compounds defined in the claims and their use for the treatment of oxidant-induced-toxicity: see in particular claims 1, 8 examples and scheme 1 *; | [Y]WO0043395 (NAT JEWISH MED & RES CENTER [US], et al) [Y] 1-3,7-13 * See compounds defined in the claims and in pages 20, 31, 42, 45, 49, 52, 55, 61, and their use for the treatment of ischemic injuries, stroke, and other associated conditions: see page 12, lines 10-12; claims 1, 11, 17, 33. See the dosages indicated in page 16 *; | [Y] - MACKENSEN G B ET AL, "Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, (20010701), vol. 21, no. 13, ISSN 0270-6474, pages 4582 - 4592, XP002954859 [Y] 1-3,7-13 * See abstract, figure 1, results and discussion: porphyrin compounds administered after 3, 6, 9, 12 hours after focal ischemia, for the treatment of ischemic injury * | International search | [Y]US5854210 (BURHOP KENNETH E [US], et al); | [Y]US2007072825 (WILLIAMS WILLIAM [US]); | [X]US2008021007 (BATINIC-HABERLE INES [US], et al); | [Y] - THIYAGARAJAN ET AL., "Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.", BRITISH JOURNAL OF PHARMACOLOGY, (2004), vol. 142, pages 899 - 911, XP008148891 DOI: http://dx.doi.org/10.1038/sj.bjp.0705811 |